← Back to all trials
Recruiting
NCT05645354
SmokefreeSGM, A Text-based Smoking Cessation Feasibility Trial for Sexual and Gender Minority Groups
Conditions: Smoking Cessation
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 80
Sponsor: The University of Texas Health Science Center, Houston
Location: United States
Summary
The purpose of this study is to test the feasibility and acceptability of Smokefree Sexual and Gender Minority (SGM), an SGM-tailored version of the SmokefreeTXT text messaging program
Eligibility Criteria
Inclusion Criteria:Self-identify as an LGBTQ+ individualCurrently live in TexasHave smoked at least 100 cigarettes in their lifetime, smoke every day, and smoke greater than or equal to 5 cigarettes a dayAre willing to quit smoking in the next 15 daysHave a cell phone number with an unlimited short message service (SMS) planHave a positive cotinine saliva test to indicate their smoking statusExclusion Criteria:Have a prepaid cell phone plan (pay-as-you-go plan)Have a cell phone number that does not work and/or is registered to someone elseHave inadequate equipment/devices (i.e., webcam, speakers, mic) for participating in telehealth sessions via Microsoft Teams, Webex, or Zoom AND cannot meet in-personPregnant or breastfeeding persons (nicotine patches are not generally recommended to this groups since nicotine can affect fetal and neonatal brain development)Contraindication for nicotine patches.
Absolute contraindications include: severe eczema or serious skin conditions, allergy to nicotine patches, pregnancy, breastfeeding, heart attack in the past 2 months, ongoing angina, peptic ulcer disease, arrhythmia, or uncontrolled blood pressure.
Potential contraindications include: stroke in the past 6 months, insulin therapy, and a current diagnosis of liver, kidney, or heart disease.
Study participants reporting a potential contraindication will require approval from their primary care provider and/or other treating physician (e.g., psychiatrist) to use nicotine patches.
If the request is denied or not returned in 2 weeks, potential study participants will be excluded from the study.Current use of tobacco cessation medicationsEnrollment in another smoking cessation studyNon-English speakers
Source: ClinicalTrials.gov (NCT05645354). StuddyBuddy aggregates publicly available trial information.